4
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Abordaje de la hiperpotasemia: desde urgencias a la unidad de hospitalización domicilio Translated title: Management of hyperkalemia: from the emergency department to the home hospitalization unit

      case-report

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Resumen La hiperpotasemia es una anomalía eléctrica común que puede empeorar arritmias cardíacas y aumentar significativamente la mortalidad. El envejecimiento progresivo de la población sumado a la mayor incidencia de entidades como la diabetes mellitus (DM), enfermedades cardiovasculares (ECV) o enfermedad renal crónica (ECV) así como el creciente uso de inhibidores del sistema renina angiotensina aldosterona (RAASi) ha provocado que sea un problema frecuente al que tenga que enfrentarse el clínico en su día a día. Presentamos un caso de un paciente ingresado a cargo de la Unidad de Hospitalización a Domicilio de San Juan de Alicante que presentaba un cuadro de inicio súbito y clínica inespecífica debido a una hiperpotasemia grave. Tras estabilización previa en el servicio de urgencias, se realizó́ una combinación de tratamiento con fármacos RAASi, diuréticos de asa y resinas de intercambio catiónico (patiromero) presentando una mejoría de la sintomatología y control de la potasemia.

          Translated abstract

          Abstract Hyperkalemia is a common electrical abnormality that can worsen cardiac arrhythmias and significantly increase mortality. The progressive aging of the population added to the higher incidence of entities such as diabetes mellitus (DM), cardiovascular diseases (CVD) or chronic kidney disease (CVD) as well as the increasing use of renin angiotensin aldosterone system inhibitors (RAASi) has caused make it a frequent problem that clinicians have to face in their day-to-day life. We present a case of a patient admitted to the San Juan de Alicante Home Hospitalization Unit who presented a sudden onset and nonspecific clinical picture due to severe hyperkalemia. After prior stabilization in the emergency department, a combination of treatment with RAASi drugs, loop diuretics and cation exchange resins (patiromer) was performed, presenting an improvement in symptoms and control of potassium levels.

          Related collections

          Most cited references10

          • Record: found
          • Abstract: found
          • Article: not found

          Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors.

          Hyperkalemia increases the risk of death and limits the use of inhibitors of the renin-angiotensin-aldosterone system (RAAS) in high-risk patients. We assessed the safety and efficacy of patiromer, a nonabsorbed potassium binder, in a multicenter, prospective trial.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial.

            Hyperkalemia is a potentially life-threatening condition predominantly seen in patients treated with renin-angiotensin-aldosterone system (RAAS) inhibitors with stage 3 or greater chronic kidney disease (CKD) who may also have diabetes, heart failure, or both.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              European Resuscitation Council Guidelines for Resuscitation 2015: Section 4. Cardiac arrest in special circumstances.

                Bookmark

                Author and article information

                Journal
                had
                Hospital a Domicilio
                Hosp. domic.
                Centro Internacional Virtual de Investigación en Nutrición (CIVIN) (Alicante, Alicante, Spain )
                2530-5115
                June 2021
                : 5
                : 2
                : 125-130
                Affiliations
                [2] Sant Joan d'Alacant orgnameHospital Universitario de San Juan de Alicante orgdiv1Unidad de Hospitalización a Domicilio España
                [1] Sant Joan d'Alacant orgnameHospital Universitario de San Juan de Alicante orgdiv1Servicio de Urgencias Hospitalarias España
                Article
                S2530-51152021000200005 S2530-5115(21)00500200005
                10.22585/hospdomic.v5i2.130
                69bf1030-2910-47b2-a4c1-53ae15378c02

                This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

                History
                : 31 January 2021
                : 24 February 2021
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 10, Pages: 6
                Product

                SciELO Spain

                Categories
                Notas clínicas

                Sistema Renina-Angiotensina,Hyperkalemia,Therapeutics,Renin-Angiotensin System,Hiperpotasemia,Terapéutica

                Comments

                Comment on this article